Amy M. Weeks

Amy M. Weeks

Auto-generated profile, based on publicly available information

Amy M. Weeks

Department of Biochemistry, University of Wisconsin – Madison, Madison, WI, USA 53706

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2017 in Science
Verified
Journal Article
Closed access
SLShixian Lin
Shixian Lin
XYXiaoyu Yang
Xiaoyu Yang
SJShang Jia
Shang Jia
AWAmy M. Weeks
Amy M. Weeks
MHMichael Hornsby
Michael Hornsby
CCChristopher J. Chang
Christopher J. Chang
Targeting proteins at the other sulfur: As the only amino acid with a thiol (SH) group, cysteine is easily targeted for site-selective protein modifications. Hydrophobic methionine also has sulfur in its side chain, but its capping methyl group has hindered analogous targeting efforts. Lin et al. introduce a complementary protocol to tether new substituents exclusively to methionine, even in the presence of cysteine. They used an oxaziridine group as an oxidant to form sulfimide (S=N) linkages. The approach allowed antibody-drug conjugation and chemoproteomic screening for reactive methionine surface residues. Science , this issue p. 597

30 October 2019 in Chemical Reviews
Verified
Journal Article
Closed access
AWAmy M. Weeks
Amy M. Weeks
JWJames A. Wells
James A. Wells

20 November 2017 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
AWAmy M Weeks
Amy M Weeks
JWJames A Wells
James A Wells
A comprehensive characterization of peptide ligase specificity using proteome-derived peptide libraries enables the identification of 72 new subtiligases and their application to site-specific bioconjugation and sequencing of the cellular N terminome. Enzyme-catalyzed peptide ligation is a powerful tool for site-specific protein bioconjugation, but stringent enzyme-substrate specificity limits its utility. We developed an approach for comprehensively characterizing peptide ligase specificity for N termini using proteome-derived peptide libraries. We used this strategy to characterize the ligation efficiency for >25,000 enzyme-substrate pairs in the context of the engineered peptide ligase subtiligase and identified a family of 72 mutant subtiligases with activity toward N-terminal sequences that were previously recalcitrant to modification. We applied these mutants individually for site-specific bioconjugation of purified proteins, including antibodies, and in algorithmically selected combinations for sequencing of the cellular N terminome with reduced sequence bias. We also developed a web application to enable algorithmic selection of the most efficient subtiligase variant(s) for bioconjugation to user-defined sequences. Our methods provide a new toolbox of enzymes for site-specific protein modification and a general approach for rapidly defining and engineering peptide ligase specificity.

23 February 2022 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
JBJames R. Byrnes
James R. Byrnes
AWAmy M. Weeks
Amy M. Weeks
ESEric Shifrut
Eric Shifrut
JCJulia Carnevale
Julia Carnevale
LKLisa Kirkemo
Lisa Kirkemo
JWJames A. Wells
James A. Wells
Immunosuppressive factors in the tumor microenvironment (TME) impair T cell function and limit the antitumor immune response. T cell surface receptors and surface proteins that influence interactions and function in the TME are proven targets for cancer immunotherapy. However, how the entire surface proteome remodels in primary human T cells in response to specific suppressive factors in the TME remains to be broadly and systematically characterized. Here, using a reductionist cell culture approach with primary human T cells and stable isotopic labeling with amino acids in cell culture–based quantitative cell surface capture glycoproteomics, we examined how two immunosuppressive TME factors, regulatory T cells (Tregs) and hypoxia, globally affect the activated CD8+ surface proteome (surfaceome). Surprisingly, coculturing primary CD8+ T cells with Tregs only modestly affected the CD8+ surfaceome but did partially reverse activation-induced surfaceomic changes. In contrast, hypoxia drastically altered the CD8+ surfaceome in a manner consistent with both metabolic reprogramming and induction of an immunosuppressed state. The CD4+ T cell surfaceome similarly responded to hypoxia, revealing a common hypoxia-induced surface receptor program. Our surfaceomics findings suggest that hypoxic environments create a challenge for T cell activation. These studies provide global insight into how Tregs and hypoxia remodel the T cell surfaceome and we believe represent a valuable resource to inform future therapeutic efforts to enhance T cell function.

17 May 2011 in Biochemistry
Verified
Journal Article
Closed access
AWAmy M. Weeks
Amy M. Weeks
MCMichelle C. Y. Chang
Michelle C. Y. Chang

9 October 2023 in Cell Chemical Biology
Verified
Journal Article
Closed access
HBHaley N. Bridge
Haley N. Bridge
WLWilliam Leiter
William Leiter
CFClara L. Frazier
Clara L. Frazier
AWAmy M. Weeks
Amy M. Weeks